Sell NowMedium
BHVN has broken below key support at the 50-day moving average, triggering a Support Failure pattern and now trades under its declining short-term EMAs. Short-term EMAs are sloping down, and price continues to reject at the EMA cluster, favoring selling on rallies into resistance. Medium-term bias remains bearish in Stage 4, while the long-term uptrend stays intact above the 200-day SMA. Timing aligns for immediate execution on failed rallies into EMAs.
- ↑Q4 net sales hit $190 M (+440% YoY) with 1.6 M+ prescriptions
- ↑Pfizer collaboration injects $500 M, boosting cash and overseas launch
- ↓Q4 adjusted net loss of $125 M and negative earnings yield
Full analysis →